Javaherirenani, Razieh http://orcid.org/0000-0001-8315-1370
Mortazavi, Seyede Salehe http://orcid.org/0000-0003-4565-9688
Shalbafan, Mohammadreza http://orcid.org/0000-0002-4536-3441
Ashouri, Ahmad http://orcid.org/0000-0002-4444-4530
Farani, Abbas Ramezani http://orcid.org/0000-0001-6910-237X
Article History
Received: 28 June 2022
Accepted: 17 November 2022
First Online: 28 November 2022
Declarations
:
: The trial was approved by the Research Ethics Committee of the Iran University of Medical Sciences (IR.IUMS.REC.1400.595) and all methods were performed in accordance with the relevant guidelines and regulations. Written informed consent was obtained from all participants. Patients were informed that their participation was a voluntary activity and that they had the right to leave the study at any time with no negative effect on their treatment. They were also informed about confidentiality. The trial was registered at the Iranian Registry of Clinical Trials on 16/10/2021 (ExternalRef removed; IRCT ID: IRCT20210214050353N1).
: Not applicable.
: The authors declare no conflict of interest.